Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1731-1740 of 9365

Page
per page
  1. BAN ORL 24
    A3219 BAN ORL 24
    Summary: NOP receptor antagonist, potent and selective
      Soluble in DMSO
  2. Bardoxolone
    A3220 Bardoxolone
    Target: COX|iNOS
    Summary: Once-a-day treatment for CKD
      ≥49.2 mg/mL
  3. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL
  4. Baricitinib phosphate
    A3222 Baricitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥172.6 mg/mL
  5. BAY 61-3606
    A3227 BAY 61-3606
    Target: Syk
    Summary: Syk Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.94 mg/mL
  6. BAY 61-3606 dihydrochloride
    A3228 BAY 61-3606 dihydrochloride
    Summary: Syk tyrosine kinase inhibitor
      Soluble in DMSO
  7. Bay 65-1942 HCl salt
    A3230 Bay 65-1942 HCl salt
    Summary: IKKβ kinase inhibitor
      Soluble in DMSO
  8. Bazedoxifene
    A3232 Bazedoxifene
    Summary: Estrogen receptor modulator
      Soluble in DMSO
  9. Bazedoxifene acetate
    A3233 Bazedoxifene acetate
    Summary: Estrogen receptor modulator
      insoluble in H2O; ≥182 mg/mL
  10. Benfotiamine
    A3236 Benfotiamine
    Summary: Drug for painful nerve condition
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO

Items 1731-1740 of 9365

Page
per page